Bill Text: NY S02058 | 2013-2014 | General Assembly | Introduced
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Requires certain health insurance policies and contracts to provide coverage for human leukocyte antigen testing, also referred to as histocompatible locus antigen testing, for A, B, and DR antigens, for utilization in tissue typing for bone marrow testing.
Spectrum: Partisan Bill (Democrat 9-0)
Status: (Introduced - Dead) 2014-01-13 - PRINT NUMBER 2058A [S02058 Detail]
Download: New_York-2013-S02058-Introduced.html
Bill Title: Requires certain health insurance policies and contracts to provide coverage for human leukocyte antigen testing, also referred to as histocompatible locus antigen testing, for A, B, and DR antigens, for utilization in tissue typing for bone marrow testing.
Spectrum: Partisan Bill (Democrat 9-0)
Status: (Introduced - Dead) 2014-01-13 - PRINT NUMBER 2058A [S02058 Detail]
Download: New_York-2013-S02058-Introduced.html
S T A T E O F N E W Y O R K ________________________________________________________________________ 2058 2013-2014 Regular Sessions I N S E N A T E (PREFILED) January 9, 2013 ___________ Introduced by Sen. LATIMER -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance AN ACT to amend the insurance law, in relation to requiring policies and contracts of insurance providing hospital, surgical, or medical care coverage to include coverage for human leukocyte antigen testing THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: 1 Section 1. Subsection (i) of section 3216 of the insurance law is 2 amended by adding a new paragraph 30 to read as follows: 3 (30) EVERY POLICY WHICH PROVIDES HOSPITAL, SURGICAL, OR MEDICAL CARE 4 COVERAGE OR PROVIDES REIMBURSEMENT FOR LABORATORY TESTS OR REIMBURSEMENT 5 FOR DIAGNOSTIC X-RAY SERVICES SHALL PROVIDE COVERAGE FOR HUMAN LEUKOCYTE 6 ANTIGEN TESTING, ALSO REFERRED TO AS HISTOCOMPATIBLE LOCUS ANTIGEN TEST- 7 ING, FOR A, B, AND DR ANTIGENS FOR UTILIZATION IN TISSUE TYPING FOR BONE 8 MARROW TESTING. 9 S 2. Subsection (1) of section 3221 of the insurance law is amended by 10 adding a new paragraph 19 to read as follows: 11 (19) EVERY GROUP OR BLANKET POLICY DELIVERED OR ISSUED FOR DELIVERY IN 12 THIS STATE WHICH PROVIDES HOSPITAL, SURGICAL, OR MEDICAL CARE COVERAGE 13 SHALL PROVIDE COVERAGE FOR HUMAN LEUKOCYTE ANTIGEN TESTING, ALSO 14 REFERRED TO AS HISTOCOMPATIBLE LOCUS ANTIGEN TESTING, FOR A, B, AND DR 15 ANTIGENS FOR UTILIZATION IN TISSUE TYPING FOR BONE MARROW TESTING, 16 EXCEPT THAT THIS PROVISION SHALL NOT APPLY TO A POLICY WHICH COVERS 17 PERSONS EMPLOYED IN MORE THAN ONE STATE OR THE BENEFIT STRUCTURE OF 18 WHICH WAS THE SUBJECT OF COLLECTIVE BARGAINING AFFECTING PERSONS WHO ARE 19 EMPLOYED IN MORE THAN ONE STATE. 20 S 3. Section 4303 of the insurance law is amended by adding a new 21 subsection (jj) to read as follows: 22 (JJ) A MEDICAL EXPENSE INDEMNITY CORPORATION, A HOSPITAL SERVICE 23 CORPORATION OR A HEALTH SERVICE CORPORATION WHICH PROVIDES COVERAGE FOR EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD05133-01-3 S. 2058 2 1 HOSPITAL, SURGICAL, OR MEDICAL CARE SHALL PROVIDE COVERAGE FOR HUMAN 2 LEUKOCYTE ANTIGEN TESTING, ALSO REFERRED TO AS HISTOCOMPATIBLE LOCUS 3 ANTIGEN TESTING, FOR A, B, AND DR ANTIGENS FOR UTILIZATION IN TISSUE 4 TYPING FOR BONE MARROW TESTING, EXCEPT THAT THIS PROVISION SHALL NOT 5 APPLY TO A CONTRACT WHICH COVERS PERSONS EMPLOYED IN MORE THAN ONE STATE 6 OR THE BENEFIT STRUCTURE OF WHICH WAS THE SUBJECT OF COLLECTIVE BARGAIN- 7 ING AFFECTING PERSONS WHO ARE EMPLOYED IN MORE THAN ONE STATE. 8 S 4. This act shall take effect on the first of January next succeed- 9 ing the date on which it shall have become a law and shall apply to all 10 policies and contracts issued, renewed, modified, altered, or amended on 11 or after such effective date. Effective immediately any rules or regu- 12 lations necessary for the implementation of this act on its effective 13 date shall be promulgated, and any other measures necessary for the 14 implementation of this act on its effective date shall be taken, on or 15 before such effective date.